Westfield Capital Management
EXAS

Westfield Capital Management’s Exact Sciences EXAS Stock Holding History

Westfield Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-281,730
Closed -$33.3M – 242
2019
Q2 		$33.3M Buy
281,730
+275,730
+4,596% +$27.8M 0.25% 129
2019
Q1 		$520K Hold
6,000
– – ﹤0.01% 229
2018
Q4 		$379K Buy
+6,000
New +$412K ﹤0.01% 235

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Westfield Capital Management's EXAS Position: Q3 2019 in Review

Westfield Capital Management sold out of Exact Sciences (EXAS) in Q3 2019, closing a stake of 281,730 shares — an estimated $33.3M sold.

Westfield Capital Management first reported a position in EXAS in Q4 2018 and held it in 3 quarters. The position peaked at $33.3M in Q2 2019. 475 funds tracked by Wall St. Rank hold EXAS as of Q3 2019.

  • Westfield Capital Management reported no remaining Exact Sciences position as of Q3 2019 after selling out during the quarter.
  • Westfield Capital Management sold 281,730 Exact Sciences shares in Q3 2019, an estimated $33.3M.
  • Westfield Capital Management first reported a position in Exact Sciences in Q4 2018 and held it in 3 quarters.
  • Westfield Capital Management's Exact Sciences position peaked at $33.3M in Q2 2019.
  • 475 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2019.

Based on Westfield Capital Management's 13F filing for Q3 2019, filed 8 Nov 2019.